| |
|
Form Serial Number: |
DA20240916E00107
|
| 1.
Date of relevant event: |
11/09/2024
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02228 |
| 4.
Name of listed corporation: |
QuantumPharm Inc. - P |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
3,413,523,761 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
Wen |
| (Other names) |
Shu Hao |
|
|
|
| 10.
Name of director (Chinese): |
温书豪 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1213 | The number of shares in which you are interested has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2201 | Interest of corporation controlled by you |
|
| 2201 | Interest of corporation controlled by you |
|
2,045,000 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 730,890,183 | 21.40 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 728,845,183 | 21.35 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| |
| 2307 | Founder of a discretionary trust who can influence how the trustee exercises his discretion |
| |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| QuantumPharm Roc Holdings Limited | Sertus Chambers, P.O. Box 905, Quastisky Building, Road Town, Tortola, British Virgin Islands | QuantumPharm Holdings Limited | 100.00 | Y | |
| Crete Helix Ltd. | Sertus Chambers, P.O. Box 905, Quastisky Building, Road Town, Tortola, British Virgin Islands | MH International Holdings Limited | 99.00 | Y | |
| SeveningBAlpha Limited | Sertus Chambers, P.O. Box 905, Quastisky Building, Road Town, Tortola, British Virgin Islands | LPHappy Holding Limited | 99.00 | Y | |
| WSH Family Holdings Limited | Coastal Building, Wickham's Cay II, P. O. Box 2221, Road Town, Tortola, British Virgin Island | 温书豪 | 100.00 | N | |
| QuantumPharm Holdings Limited | Sertus Chambers, P.O. Box 905, Quastisky Building, Road Town, Tortola, British Virgin Islands | WSH Family Holdings Limited | 99.00 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| WSH Family Trust | Addresses of individuals are not displayed. | | 5103 | Founder of a discretionary trust who can influence how the trustee exercises his discretion |
| |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
方格24：由于首次公开发售前员工持股计划持股平台QuantumPharm Roc Holdings Limited无偿退回的2,045,000股份被注销，其持有的股份数及股比下降。方格27及30：根据马健与Crete Helix Ltd.及赖力鹏与SeveningBAlpha Limited签订的授权书，QuantumPharm Holdings Limited获授权行使由彼等持有股份的投票权。温书豪及QuantumPharm Holdings Limited被视为拥有Crete Helix Ltd. 持有的122,908,500股份及SeveningBAlpha Limited持有的87,814,140股份的权益。MH International Holdings Limited的权益由其信托成立人马健控制。LPHappy Holding Limited的权益由其信托成立人赖力鹏控制。温书豪被视为拥有QuantumPharm Roc Holdings Limited持有的295,996,143股份的权益并于首次公开发售前员工持股计划中享有81,093,362股份的购股权。
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
16/09/2024
(dd/mm/yyyy)
|
| |